# ClinicalTrials.gov record NCT03262610

> PeptideScanner retained ClinicalTrials.gov record NCT03262610 at 2026-07-30T19:44:52.963Z. Its registry update date was 2022-01-04, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct03262610-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2022-01-04
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03262610-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03262610-setmelanotide-v1.json
- Content SHA-256: `aacf75173626c4d7cc3870c29875b170113c2b57d2358e47d8f3859f5ffeca66`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03262610 ([`ctg-observation-nct03262610-2022-01-04-8355a81fc3bb`](#source-ctg-observation-nct03262610-2022-01-04-8355a81fc3bb))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03262610 at 2026-07-30T19:44:52.963Z. Its registry update date was 2022-01-04, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct03262610-2022-01-04-8355a81fc3bb`](#source-ctg-observation-nct03262610-2022-01-04-8355a81fc3bb))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03262610 at 2026-07-30T19:44:52.963Z. Its registry update date was 2022-01-04, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct03262610-2022-01-04-8355a81fc3bb`](#source-ctg-observation-nct03262610-2022-01-04-8355a81fc3bb))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03262610-2022-01-04-8355a81fc3bb`](#source-ctg-observation-nct03262610-2022-01-04-8355a81fc3bb))

## Sources

<a id="source-ctg-observation-nct03262610-2022-01-04-8355a81fc3bb"></a>
- **ClinicalTrials.gov record NCT03262610 · retained source version 2022-01-04:8355a81fc3bb91e526577eaf3eefd7fb29b3a1946f58d33f6df2b8af6d4b0d57** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03262610) (`ctg-observation-nct03262610-2022-01-04-8355a81fc3bb`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03262610." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03262610-setmelanotide-v1.json SHA-256: aacf75173626c4d7cc3870c29875b170113c2b57d2358e47d8f3859f5ffeca66.